Veterinary products from the prohibition on products containing PFAS exempted.

Minnesota House Bill HF4002, introduced on March 5, 2026, seeks to amend existing state law to exempt veterinary products from the prohibition on per- and polyfluoroalkyl substances (PFAS). The bill proposes changes to Minnesota Statutes 2024, section 116.943, subdivision 8, by adding veterinary products to the list of exemptions, alongside medical devices, drugs, and biologics used in medical settings regulated by the FDA or USDA. This amendment would allow veterinary products containing PFAS to be sold and used in Minnesota, recognizing federal oversight in this area.

Supporters of HF4002 argue that the bill provides necessary flexibility for veterinary professionals by ensuring access to essential products that may contain PFAS. They contend that federal regulations already govern the safety and efficacy of these products, making additional state-level restrictions unnecessary. This exemption is seen as a way to align state law with federal standards, facilitating the continued availability of important veterinary treatments.

Critics of HF4002 express concern that exempting veterinary products from the state's PFAS prohibition could undermine efforts to reduce environmental and health risks associated with these substances. They worry that allowing PFAS in veterinary products may contribute to broader contamination issues, as PFAS are known for their persistence in the environment and potential adverse health effects. Opponents advocate for maintaining strict state-level restrictions to protect public health and the environment.